Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2026-01-27 00:00:00 ET · period of report 2026-01-26 · accession 0001493152-26-003805 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-27 | 2026-01-26 | ABEO | Charles Faith L. | Dir | A - Grant | $0.00 | +37.3K | 176.4K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-26 | A | A | 37,313 | $0.00 | 176,407 | D | — | — | (F1) All of the restricted stock will vest on January 26, 2027. |